The KaNDy Therapeutics brand, founded in 2017 (United Kingdom), from 2081 sister brands and 17477 competing brands. The KaNDy Therapeutics brand is owned by BAYER, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is DE000BAY0017. KaNDy Therapeutics belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BAYER
(KaNDy Therapeutics)
over 5 years*
EUR 13.84